klow peptide blend bpc-157 tb-500 ghk-cu kpv (GHK-CU, TB-500, BPC-157, KPV) KLOW BLEND Peptide (80mg) |

(2021) This placebo-controlled clinical study tested copper tripeptide serum in a double-blind design, providing the gold-standard clinical evidence that followed from this laboratory foundation

Red Blood Cells: Promotes healthy blood and oxygen circulation

Combined success rate: 8595%

AACR Meeting Abstracts (2018) 78:4563

Stem Cell Therapy Involves harvesting and re-injecting autologous mesenchymal stem cells

Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval